Cardiovascular safety of evogliptin dual and triple therapy in patients with type 2 diabetes: a nationwide cohort study

Objective To investigate the risk of cardiovascular events associated with commonly used dual and triple therapies of evogliptin, a recently introduced dipeptidyl peptidase-4 inhibitor (DPP4i), for managing type 2 diabetes in routine clinical practice.Design A retrospective cohort study.Setting Kore...

Full description

Bibliographic Details
Main Authors: Sohee Park, Ju-Young Shin, Han Eol Jeong, Sangmo Hong, In-Sun Oh, Sung Hoon Yu, Chang Beom Lee
Format: Article
Language:English
Published: BMJ Publishing Group 2024-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/4/e077084.full